HIV Change of guard

Introduction

The HIV market generated $7.4 billion of sales in 2005 and experienced a CAGR of 13.3% from 2001-2005, making it one of the fastest growing infectious diseases sub sectors. Despite the antiretroviral market's relative immaturity, many older flagship products such as Combivir are expected to lose patent protection before 2015.

Scope of this report

In-depth analysis of the current HIV market across the major Western markets (US, France, Germany, Italy, Spain, UK)

Thorough assessment of underlying commercial and clinical influencing factors shaping the antiretroviral market

Detailed sales forecasts for the three major antiretroviral classes, molecules and brands in each of the six major markets

Case study analysis of the competitive environment and critical success factors in the Protease Inhibitor class

Research and analysis highlights

By 2015 the global antiretroviral market is forecast to be valued at more than $10 billion with a modest CAGR of 4.1%. The main contributor to growth will be the new drug classes such as integrase- and entry inhibitors.

Since the advent of HAART, HIV has turned into a chronic disease with an average life expectancy similar to that of Type 2 diabetes, emphasizing the importance of side effect profiles associated with long-term use.

The launch of several new products from new classes such as integrase inhibitors, CCR5 inhibitors from 2007, and recently launched PIs, will cause the salvage market to decline. Despite proven synergy between Fuzeon and the new drugs, use of the former is predicted to decline.

Key reasons to read this report

Understand the constantly evolving market dynamics of antiretroviral (ARV) drugs

Explore the impact of pending patent expiries and generic incursion on the ARV market, including product-specific case studies

Obtain full global, country, class and product-specific forecasts of currently marketed and pipeline ARVs from 2005 to 2015.

Published: 22 December 2006

Format: PDF
Table of Contents
Price: $15,200.00 / GBP8,360.00